Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in China
Clinical trial NCT06362460 · COMPLETED
Trial details
- NCT number
- NCT06362460
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2023-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.